SightfileU.S. market data from official filings

Phio Pharmaceuticals Corp (PHIO)

Name: Phio Pharmaceuticals Corp (PHIO) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001533040 · EDGAR filings · Updated 2026-07-21

Phio Pharmaceuticals Corp (PHIO) has reported institutional ownership of 5.8%, with 24 institutional managers holding positions valued at $815.0K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

5.8%

Institutional managers

Reported 13F value

$815.0K

Insider activity

25 trans.

$49.3K net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-21 — Current report (8-K) filed
2026-06-29 — Insider transaction reported (Form 4)
2026-05-07 — Quarterly report (10-Q) filed
2026-05-07 — Current report (8-K) filed
2026-04-08 — Current report (8-K) filed
2026-04-08 — Prospectus supplement (424B5) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Phio Pharmaceuticals Corp has 24 institutional holders and institutional ownership of 5.8%.

Insider activity

Insiders reported 25 transactions (10 buys, 0 sells) across 7 reporting insiders, with a net reported value of $49.3K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-05 (recurring since 2023-03-22) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-01-26 (recurring since 2022-03-03) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Tempest Therapeutics Inc (TPST) · BioCardia Inc (BCDA) · INTENSITY THERAPEUTICS INC (INTS) · CELLECTAR BIOSCIENCES INC (CLRB) · ABVC BIOPHARMA INC (ABVC) · Cocrystal Pharma Inc (COCP)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.